Form 4: Praxis Precision Medicines CEO Marcio Souza Reports Stock Transaction
SEC Form 4 Filing
CEO Marcio Souza reports disposition of 401 shares of Praxis Precision Medicines common stock to cover tax obligations related to vesting restricted stock units.
Summary
- On February 12, 2025, Marcio Souza, the CEO of Praxis Precision Medicines, Inc., disposed of 401 shares of common stock.
- The shares were withheld by the issuer to satisfy tax withholding obligations related to the vesting of previously reported restricted stock units.
- The transaction was executed at a price of $85.4 per share.
- Following the transaction, Souza directly owns 53,559 shares of common stock and indirectly owns 3,000 shares held by their spouse.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations, which is a normal part of executive compensation.
Industry Context
Form 4 filings are standard disclosures required by the SEC when corporate insiders, like CEOs, buy or sell their company's stock. These filings provide transparency into insider transactions and can be monitored by investors for insights into management's perspective on the company's value and prospects.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine sale of shares to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/12/2025 | Date of stock transaction (disposal of shares). |
| 02/14/2025 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.